City of Hope CEO Robert Stone is leading initiatives to expand access to personalized oncology care and address systemic health-care inequities.

These efforts aim to ensure that cutting-edge treatments are affordable and widely available, as survival rates for cancer patients often depend on their ability to access specialized medical expertise.

Stone said that the organization is working to dismantle barriers to deliver expert oncology care. The City of Hope currently provides oncology services across four states [1]. The initiative focuses on making personalized treatments a standard of care, rather than a privilege for those with significant financial means or proximity to major medical hubs.

Financial barriers remain a significant hurdle for patients in remote or underserved regions. For example, patients in Hawai‘i spent over $230 million on out-of-state cancer care between 2021 and 2023 [2]. This spending highlights the gap in local availability of specialized treatments and the resulting financial burden on patients who must travel for life-saving care.

While Stone said he is optimistic about the ability to expand these services, other reports suggest a more complex global outlook. A report cited by MSN indicated that global health-care inequities may limit improvements in cancer care even as cases soar in the coming decades [3].

Despite these challenges, the push for personalized care involves integrating new technologies and workflows to make treatment more precise. The goal is to shift the model of care so that the patient's location or socioeconomic status does not determine their medical outcome.

"Survival equals access," Stone said.

“"Survival equals access."”

The push for personalized oncology reflects a broader shift in U.S. medicine toward precision care, but the high cost of out-of-state travel for specialized treatment reveals a persistent geographic divide. While institutional expansions by networks like City of Hope can bridge these gaps, the tension between optimistic leadership goals and reports of soaring global cancer rates suggests that systemic inequities may outpace the speed of medical infrastructure growth.